WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
The BASL community is profoundly saddened by the death of Dr Ahmed Elsharkawy.
Read our tribute on the News page Here
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
Falk Foundation, BASL, British Liver Trust Awards 2026 - Applications Open
Read moreThe Falk Foundation, BASL, British Liver Trust Awards are supported by the Falk Foundation.
Falk Foundation, BASL and the British Liver Trust all agree in the power of shared understanding to improve patient outcomes. These awards recognise the need to share excellence in clinical service development and improvements that have clear benefit for people with liver disease. Such work is rarely that of one individual or discipline, thus these awards are designed to enable teams to develop an idea or continue their work.
The awards represent an opportunity to achieve national recognition as well as financial support for career progression.
Falk Foundation / BASL Innovation Award
One award up to a value of £2,000 for a project proposal in start-up, which would be completed prospectively over 12-24 months.
The lead applicant will need a local mentor to support the project and will be supported to ensure the success of the project.
The award is identified to facilitate research in an area relevant to improving either clinical service development or offering a benefit to patients with liver disease.
Falk Foundation / BASL Quality and Service Improvement Awards
Two awards with a value of £1,000 to recognise work and projects in progress and / or completed within the last 3 years for which evidence of benefit can be shown.
These awards are open to any team of healthcare professionals working in liver disease developing initiatives that have improved patient care.
Applications for both Awards are via the BASL website with a separate application form for each Award.
Click on the appropriate link below to start your application:
Innovation Award > CLICK HERE
Quality and Service Improvement Awards > CLICK HERE
Please download a copy of the Guidance for Applicants document before making your application:
Download Falk_Foundation_BASL_Award_Guidance_for_Applicants_2026.pdf
NB: these are team awards and the lead applicant for both Awards must be a BASL member.
Important dates 2026:
Applications Open 30th March
Applications Deadline - 17:00hrs 5th June
Notification of winners by 10th July
Presentation of the Awards with be during the BASL 2026 Annual Meeting at the ICC, Newport, Wales: 6th - 9th October.
BASL is committed to promoting equality, diversity and inclusion in all aspects of its work and is actively promoting equal opportunities to our activities, including our awards, for all our members regardless of their background, place of work or professional group. We welcome applications from all disciplines in the field of liver healthcare.
A Tribute to Dr Ahmed Elsharkawy
Read more
The BASL community is profoundly saddened by the death of Dr Ahmed Elsharkawy.
Ahmed was Consultant Hepatologist at the Queen Elizabeth Hospital in Birmingham. His passion and commitment to the development of services for patients living with liver disease and viral hepatitis specifically was inexhaustible.
At BASL, he was both Chair of the British Viral Hepatitis Group and, more recently, Treasurer where he had a major impact on our society. He undertook this role in a way that all that knew him would recognise; he was honest, thoughtful, direct, and always guided by what was going to be the best for the future of BASL and UK Hepatology.
He will be greatly missed by the UK and International Hepatology communities. At BASL we will miss his never-ending enthusiasm, his wise counsel, and above all his commitment to improving care for patients living with liver disease.
Our thoughts are with his family, friends and colleagues at this difficult time.
Clinical Research Fellow in Hepatology x 2 - South West Liver Unit, University Hospitals Plymouth NHS Trust
Read moreFunding is for 2 Clinical Research Fellows in Hepatology to contribute to the further development of an extensive research program. These posts will commence in September on a fixed term contract for 12 months in the first instance, renewable for a maximum of 3 years depending on progress towards an MD or PhD.
There has been significant investment and growth in liver research at the Peninsula Medical School, with excellent laboratory facilities present adjacent to Derriford Hospital at the Derriford Research Facility where the Hepatology Research Group ( https://www.plymouth.ac.uk/research/hepatology-research-group ) and the Centre of Environmental Hepatology (https://www.plymouth.ac.uk/research/centre-of-environmental-hepatology ) are based. Active clinical research programs span alcohol related liver disease, the use of big data and AI for early liver disease detection, to mechanisms of protection from viral hepatitis. The Centre of Environmental Hepatology, led by Professor Shilpa Chokshi, has a cutting edge and expanding program of translational and basic science work looking at the impact of micro- and nanolastics on liver health. The research programs are delivered and supported by a strong team of senior post-doctoral scientists, clinical research fellows, and PhD students.
Read and apply via the NHS Jobs website under reference 216-G3-HEP7796852
Closing date: 6th April 2026
Informal enquiries welcomed with interviews scheduled for April - please contact Professor Matthew Cramp or Professor Ashwin Dhanda, matthew.cramp@nhs.net or ashwin.dhanda@plymouth.ac.uk.
EASL MASLD Guidelines Academy Programme
Read moreThe EASL Guidelines Academy is a training initiative designed to help doctors, nurses, and other healthcare professionals apply the latest official clinical guidelines in real-world practice.
This EASL Guidelines Academy focuses specifically on metabolic dysfunction-associated steatotic liver disease (MASLD) and provides hands-on, intensive training to help participants better understand the disease, improve screening and diagnosis, confidently use the latest tools and procedures, work effectively in multidisciplinary teams, and promote liver disease awareness and prevention.
Modules 1–4 are open to hepatologists, endocrinologists, and other relevant specialists who are board-certified or in their final year of training. Module 5 is dedicated to nurses and allied health professionals involved in MASLD care (MDs may apply, but nurses will be prioritised).
Visit the EASL website to learn more> https://easl.eu/easl-masld-guidelines-academy/
The British Liver Trust has launched a new campaign to mark Rare Disease Day (February 28th)
Read moreNo One Left Behind focusses on lesser-known liver diseases which are misunderstood and lack the profile of other health conditions.
Rare liver diseases affect tens of thousands of adults and children across the UK every day. Delays in diagnosis, limited access to specialist care, and low public and professional awareness contribute to inequities in treatment and outcomes for those living with these conditions. No One Left Behind aims to provide support to everyone affected, raise awareness and increase understanding, promote earlier diagnosis and more investment in research.
Find out more at Britishlivertrust.org.uk/nooneleftbehind.
Events
22/04/26
Register HERE
We are delighted to announce the next webinar in our 2026 series:-
Date: Wednesday 22nd April 2026
UK Time: 19:00 - 20:00
Title: Bridging the Gap: Transitioning Young Adults to Adult Healthcare
Speakers: Dr D Joshi and Dr Jeremy Nayagam - Kings College London
Format - a talk followed by a Q&A session
Platform - Zoom
FREE to attend for BASL Members and non-members. Catch up recording will only be available to BASL members.
You can register HERE
You can read the BASL Events Data Protection Disclaimer via this link before registering Download BASL Events Data Protection Disclaimer_2022.pdf
Contact: kim@basl.org.uk for any questions
BASL School of Hepatology Webinar Series is supported by sponsors including pharmaceutical companies. Pharmaceutical companies have solely provided financial sponsorship, with no input into the arrangements or agenda of the meeting. A full list of sponsors can be found below:
Ipsen 
Novo Nordisk 
Gilead 
Registration - Click HERE to register for the event
BASL X-tra is an online educational conference.
Three afternoons of multi-professional liver learning on Tuesday 28th, Wednesday 29th and Thursday 30th April 2026.
BASL X-tra will have something for everyone - multi-professional, topic-focused education delivered online.
Watch On Demand - if you are not able to attend when the sessions are live, but still want to benefit from the event, please do still register as you will then be able to watch the sessions online and for 28 days later.
Day 1: 'Exploring Alcohol related liver disease’ - 13:00-16:30pm
Day 2: 'Liver Transplantation: From Patient Selection to Post-Transplant Care' - joint BASL/BLNA - 12:45-16:30pm
Day 3: 'HCC 2026: Optimizing Diagnosis, Treatment, and Outcomes' - 13:00-16:30 pm
VIEW a programme > HERE
REGISTER > HERE
Registration starts from just £20 for members:
From £20 for nurses, pharmacists, AHPs, students and scientists
From £50 for trainees
From £75 for consultants
Not a BASL member? Why not consider joining > here
If you have any questions, please contact conference@basl.org.uk
We look forward to welcoming you to BASL X-tra.
BASL X-tra is supported by sponsors including pharmaceutical companies. Pharmaceutical companies have solely provided financial sponsorship, with no input into the arrangements or agenda of the meeting, except where indicated. A full list of sponsors can be found at the bottom of the agenda and below:
Ipsen Novo Nordisk Madrigal Pharmaceuticals 
Gilead
AMMF will be hosting a dedicated study day in collaboration with their Clinical Nurse Specialist (CNS) Advisory Board for registered nurses with an interest in the care of people diagnosed with HPB cancers. This Royal College of Nursing (RCN) accredited event will contribute to delegates’ continuing professional development (CPD), increasing their confidence in caring for patients diagnosed with cholangiocarcinoma.
Please note: This study day is exclusively for registered nurses attending in person. It will not be available to a virtual audience.
For further information and to register, please visit the AMMF website here: https://ammf.org.uk/hpb-nurse-study-day-2026/
AMMF look forward to welcoming you to the event.
AMMF’s 2026 European 3-day Cholangiocarcinoma Conference will take place from 13–15 May 2026 at the Radisson Blu Hotel, conveniently located next to the London Stansted Airport and rail terminal. This event is an in person event, if unable to attend in person, you have the opportunity to watch on demand shortly after the sessions have been recorded.
AMMF’s annual conference is a unique and invaluable educational opportunity for all healthcare professionals and researchers with an interest in cholangiocarcinoma.
For further information and to register, please visit the AMMF website here: https://ammf.org.uk/ammf-conference-2026/
AMMF - The Cholangiocarcinoma Charity, look forward to welcoming you to the conference.
This join BSG/BASL webinar will be held on
Wednesday 20th May 2026
18:00 to 19:00
The webinar will explore the topic of alcohol-related hepatitis and treatment of its most severe forms including transplantation. There will be an overview of diagnosis and standard management of this life-threatening condition. The current international situation regarding liver transplantation will be reviewed.
Finally, details of the UK pilot to transplant patients with severe alcohol-related hepatitis will be explained to give practitioners confidence in identifying and referring suitable patients.
You can register HERE via the BSG website.
The webinar is free to attend for BASL members and will be available to watch on-demand after the event.
Quick Links
